MIGUEL ÁNGEL
LÓPEZ RUZ
PROFESOR TITULAR DE UNIVERSIDAD
![Foto de Luis Fernando](/img/nophoto.png)
Luis Fernando
López Cortés
Publicaciones en las que colabora con Luis Fernando López Cortés (8)
2024
-
The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers
Journal of Clinical Investigation, Vol. 134, Núm. 8
2017
-
Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 3, pp. 487-494
2016
-
Effectiveness of ritonavir-boosted protease inhibitor monotherapy in clinical practice even with previous virological failures to protease inhibitor-based regimens
PLoS ONE, Vol. 11, Núm. 2
-
Protease inhibitor monotherapy is effective in controlling human immunodeficiency virus 1 shedding in the male genital tract
Clinical Microbiology and Infection, Vol. 22, Núm. 1, pp. 98.e7-98.e10
2015
-
Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 34, Núm. 11, pp. 2247-2255
2014
2008
-
Efficacy of pegylated interferon plus ribavirin treatment in HIV/ hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone
Journal of Antimicrobial Chemotherapy, Vol. 62, Núm. 6, pp. 1365-1373
2005
-
Simplicity and efficacy of a once-daily antiretroviral regimen with didanosine, lamivudine, and efavirenz in naïve patients: The VESD study
HIV Clinical Trials, Vol. 6, Núm. 6, pp. 320-328